114694-22-3

Upstream product

• 73089-93-7 1-(2'-hydroxyethyl)-1-cyclopentanol 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 114694-23-4 1-(2-Phenylsulfanyl-ethyl)-cyclopentanol 
• 114694-26-7 (1R,3aS,7aR)-1-[(R)-3-Benzenesulfonyl-1-methyl-4-(1-triethylsilanyloxy-cyclopentyl)-butyl]-4-[2-[(3S,5R)-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-indene 
• 114694-28-9 (1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-1-[(R)-1-methyl-4-(1-triethylsilanyloxy-cyclopentyl)-butyl]-octahydro-indene 
• 114694-10-9 26,27-trimethylene-1,25-dihydroxyvitamin D₃ 
• 114694-25-6 1-<2-(phenylsulfonyl)ethyl>-1-<(triethylsilyl)oxy>cyclopentane 
• 114694-24-5 1-(2-Benzenesulfonyl-ethyl)-cyclopentanol 

Relevant academic research and scientific papers

Synthesis and Biological Activity of 2,22-Dimethylene Analogues of 19-Norcalcitriol and Related Compounds

Continuing our search for Vitamin D analogues, we explored the modification of the steroidal side chain and inserted a methylene moiety in position C-22 together with either lengthening the side chain or introducing a ring at the terminal end. Our conform

Novel Convergent Synthesis of Side-Chain-Modified Analogues of 1α,25-Dihydroxycholecalciferol and 1α,25-Dihydroxyergocalciferol

A novel synthetic strategy for the preparation of side-chain-modified analogues of 1α,25-dihydroxycholecalciferol and 1α,25-dihydroxyergocalciferol was developed as a part of the extensive synthetic search for vitamin D analogues of potential anticancer a